Bellmunt, Joaquim
Hospital del Mar,
Spain
2025 Rank: 12,008
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 339 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12,008 | 12,059 |
| Total Cites | 3,976 | 4,474 |
| H-index | 27 | 29 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 120 | 120 |
| Total Cites to Single+First Authored Papers | 578 | 629 |
| Number of Single+First+Last Authored Papers | 246 | 246 |
| Total Cites to Single+First+Last Authored Papers | 1,014 | 1,106 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,429 | 2,553 |
| Ratio of Total Citations to Distinct Citing Papers | 1.64 | 1.75 |
| Self-Citation Percentage |
11.13%
|
|
Bellmunt, Joaquim
Dana-Farber Cancer Institute,
United States
2024 Rank: 5,769
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 177 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5,769 | 6,682 |
| Total Cites | 4,234 | 4,605 |
| H-index | 29 | 29 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 117 | 117 |
| Total Cites to Single+First Authored Papers | 596 | 636 |
| Number of Single+First+Last Authored Papers | 234 | 234 |
| Total Cites to Single+First+Last Authored Papers | 1,060 | 1,126 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,606 | 2,714 |
| Ratio of Total Citations to Distinct Citing Papers | 1.62 | 1.70 |
| Self-Citation Percentage |
8.06%
|
|
Bellmunt, Joaquim
Harvard Medical School,
United States
2023 Rank: 5,459
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 193 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5,459 | 5,934 |
| Total Cites | 4,963 | 5,511 |
| H-index | 34 | 35 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 117 | 117 |
| Total Cites to Single+First Authored Papers | 725 | 769 |
| Number of Single+First+Last Authored Papers | 230 | 230 |
| Total Cites to Single+First+Last Authored Papers | 1,291 | 1,387 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,061 | 3,214 |
| Ratio of Total Citations to Distinct Citing Papers | 1.62 | 1.71 |
| Self-Citation Percentage |
9.94%
|
|
Bellmunt, Joaquim
Harvard Medical School,
United States
2022 Rank: 5,768
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 220 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5,768 | 5,234 |
| Total Cites | 4,990 | 5,603 |
| H-index | 31 | 33 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 7 | 8 |
| Number of Single+First Authored Papers | 115 | 115 |
| Total Cites to Single+First Authored Papers | 759 | 828 |
| Number of Single+First+Last Authored Papers | 225 | 225 |
| Total Cites to Single+First+Last Authored Papers | 1,311 | 1,447 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,174 | 3,351 |
| Ratio of Total Citations to Distinct Citing Papers | 1.57 | 1.67 |
| Self-Citation Percentage |
10.94%
|
|
Bellmunt, Joaquim
Harvard Medical School,
United States
2021 Rank: 4,958
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 172 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4,958 | 4,414 |
| Total Cites | 7,656 | 8,540 |
| H-index | 37 | 41 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 13 | 14 |
| Number of Single+First Authored Papers | 111 | 111 |
| Total Cites to Single+First Authored Papers | 1,196 | 1,294 |
| Number of Single+First+Last Authored Papers | 214 | 214 |
| Total Cites to Single+First+Last Authored Papers | 2,004 | 2,198 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,982 | 5,240 |
| Ratio of Total Citations to Distinct Citing Papers | 1.54 | 1.63 |
| Self-Citation Percentage |
10.35%
|
|
Bellmunt, Joaquim
Harvard Medical School,
United States
2020 Rank: 6,891
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 255 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 6,891 | 6,300 |
| Total Cites | 5,513 | 6,190 |
| H-index | 30 | 33 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 114 | 114 |
| Total Cites to Single+First Authored Papers | 853 | 926 |
| Number of Single+First+Last Authored Papers | 210 | 210 |
| Total Cites to Single+First+Last Authored Papers | 1,371 | 1,517 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,740 | 3,977 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.56 |
| Self-Citation Percentage |
10.94%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.